Suresh K. Durgam - Net Worth and Insider Trading

Suresh K. Durgam Net Worth

The estimated net worth of Suresh K. Durgam is at least $1 Million dollars as of 2024-04-28. Suresh K. Durgam is the EVP, Chief Medical Officer of Intra-Cellular Therapies Inc and owns about 19,803 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $1 Million. Details can be seen in Suresh K. Durgam's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Suresh K. Durgam has not made any transactions after 2024-03-11 and currently still holds the listed stock(s).

Transaction Summary of Suresh K. Durgam

To

Suresh K. Durgam Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Suresh K. Durgam owns 1 companies in total, including Intra-Cellular Therapies Inc (ITCI) .

Click here to see the complete history of Suresh K. Durgam’s form 4 insider trades.

Insider Ownership Summary of Suresh K. Durgam

Ticker Comapny Transaction Date Type of Owner
ITCI Intra-Cellular Therapies Inc 2024-03-11 Chief Medical Officer

Suresh K. Durgam Latest Holdings Summary

Suresh K. Durgam currently owns a total of 1 stock. Suresh K. Durgam owns 19,803 shares of Intra-Cellular Therapies Inc (ITCI) as of March 11, 2024, with a value of $1 Million.

Latest Holdings of Suresh K. Durgam

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ITCI Intra-Cellular Therapies Inc 2024-03-11 19,803 73.26 1,450,768

Holding Weightings of Suresh K. Durgam


Suresh K. Durgam Form 4 Trading Tracker

According to the SEC Form 4 filings, Suresh K. Durgam has made a total of 16 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 10,162 shares on March 11, 2024, which brought Suresh K. Durgam around $672,826.

Insider Trading History of Suresh K. Durgam

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Suresh K. Durgam Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Suresh K. Durgam Ownership Network

Ownership Network List of Suresh K. Durgam

No Data

Ownership Network Relation of Suresh K. Durgam


Suresh K. Durgam Owned Company Details

What does Intra-Cellular Therapies Inc do?

Who are the key executives at Intra-Cellular Therapies Inc?

Suresh K. Durgam is the Chief Medical Officer of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include EVP & Chief Commercial Officer Mark Neumann , VP of Finance & CFO & Secretary Lawrence J. Hineline , and SVP and General Counsel Michael Halstead .

Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary

Over the past 18 months, Suresh K. Durgam made 9 insider transaction in Intra-Cellular Therapies Inc (ITCI) with a net sale of 129,431. Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 181,034 shares made by Mark Neumann , a net sale of 554,970 shares made by Sharon Mates , and a net sale of 233,341 shares made by Michael Halstead .

In summary, during the past 3 months, insiders sold 312,782 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 312,782 shares. During the past 18 months, 1,392,842 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,392,842 shares.

Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intra-Cellular Therapies Inc Insider Transactions

No Available Data

Suresh K. Durgam Mailing Address

Above is the net worth, insider trading, and ownership report for Suresh K. Durgam. You might contact Suresh K. Durgam via mailing address: C/o Inter-cellular Therapies, Inc., 430 East 29th Street, New York Ny 10016.

Discussions on Suresh K. Durgam

No discussions yet.